A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

Some gene therapy treatments use modified adeno-associated viruses (AAVs) to deliver therapeutic genetic material into a patient's cells. These AAVs are engineered to target specific cell types.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.COWbVb-l.js ...

A new study reveals that modifying the CUL5 gene enhances CAR-T cell therapy for leukemia and lymphoma. This improves cell ...

Navega Therapeutics, a leading epigenetic gene therapy company, is pleased to announce the addition of four senior advisors. The addition of these experienced entrepreneurs and scientific experts will ...

The UK has been a global leader in introducing cell and gene therapies that can potentially transform the lives of patients with debilitating diseases – but there are still many barriers to ...

A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.

“You are one of the few in the country and even in the world, you know, taking this big step — gene therapy,” said Campbell, director of the hospital’s Comprehensive Sickle Cell Disease ...

In their latest study, a team led by Jonathan Cooper, Ph.D., professor of pediatrics at WashU Medicine, has shown that gene therapy ... the accumulated material inside the cells.

A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England. About 50 people a year with the inherited blood disorder are likely ...